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Abstract
Background
Noroviruses are an important cause of gastroenteritis but little is known about disease and
re-infection rates in community settings in Asia.
Methods
Disease, re-infection rates, strain prevalence and genetic susceptibility to noroviruses were
investigated in a birth cohort of 373 Indian children followed up for three years. Stool sam-
ples from 1856 diarrheal episodes and 147 vomiting only episodes were screened for noro-
virus by RT-PCR. Norovirus positivity was correlated with clinical data, secretor status and
ABO blood group.
Results
Of 1856 diarrheal episodes, 207 (11.2%) were associated with norovirus, of which 49(2.6%)
were norovirus GI, 150(8.1%) norovirus GII, and 8 (0.4%) were mixed infections with both
norovirus GI and GII. Of the 147 vomiting only episodes, 30 (20.4%) were positive for noro-
virus in stool, of which 7 (4.8%) were norovirus GI and 23 (15.6%) GII. At least a third of the
children developed norovirus associated diarrhea, with the first episode at a median age of
5 and 8 months for norovirus GI and GII, respectively. Norovirus GI.3 and GII.4 were the
predominant genotypes (40.3% and 53.0%) with strain diversity and change in the predomi-
nant sub-cluster over time observed among GII viruses. A second episode of norovirus gas-
troenteritis was documented in 44/174 (25.3%) ever-infected children. Children with the
G428A homozygous mutation for inactivation of the FUT2 enzyme (se428se428) were at a
significantly lower risk (48/190) of infection with norovirus (p = 0.01).
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Conclusions
This is the first report of norovirus documenting disease, re-infection and genetic suscepti-
bility in an Asian birth cohort. The high incidence and apparent lack of genogroupII specific
immunity indicate the need for careful studies on further characterization of strains, asymp-
tomatic infection and shedding and immune response to further our understanding of noro-
virus infection and disease.
Introduction
Noroviruses are a leading cause of non-bacterial acute gastroenteritis (AGE) outbreaks in all
age groups worldwide and are increasingly recognized as the second most common cause of
sporadic AGE in children after rotavirus [1–3]. Noroviruses are non-enveloped, single-
stranded positive-sense RNA viruses belonging to the family Caliciviridae. The viral genome
consists of three open reading frames (ORFs), with ORF 1 encoding six non-structural proteins
including the RNA dependent RNA polymerase (RdRp). ORF 2 encodes for the major capsid
protein (VP1) and ORF 3 encodes a minor capsid protein (VP2) [4].
Noroviruses are divided into 5 genogroups (GI-GV) of which GI, GII and GIV are known
to cause gastroenteritis in humans [5, 6]. Each genogroup is further divided into genetic clus-
ters: 14 clusters in GI, 17 clusters in GII and 1 cluster in GIV have been described [7]. Among
norovirus genogroups known to infect humans, GII noroviruses are the major genogroup caus-
ing outbreaks and sporadic infections worldwide and also predominate in community studies
[8, 9].
Recent reports on norovirus infections from India were hospital-based studies of acute gas-
troenteritis [10–12], similar to the majority of reports in children from other parts of the
world. There are limited data on norovirus infections in the community mainly because of the
difficulty in conducting such studies, whether cross-sectional or longitudinal. Very recently, a
Peruvian birth cohort study found that 71% of 189 children followed upto 2 years of age, expe-
rienced norovirus associated diarrhea, that genogroup II infections were common and that
repeat infections by the same genogroup were common, but repeat infections by the same
genotype were rare[13].We have previously reported a limited comparison of pediatric norovi-
rus disease and strain distribution between children with diarrhea in the hospital and in this
cohort and asymptomatic children from this cohort that demonstrated the importance of noro-
viruses as gastrointestinal pathogens in Indian children, the predominance of GII noroviruses
and a low prevalence of GI [9].
Some studies have examined the course of norovirus infection, susceptibility and disease in
healthy adults through volunteer and outbreak studies, but few are population-based estimates
of norovirus disease burden in a community [8, 13]. The present study provides disease inci-
dence and re-infection rates of norovirus genogroupsI and II, with evaluation of putative host
markers of susceptibility in an Asian population followed from birth to the age of 3 years.
Materials and Methods
Study Design
All 1856 diarrheal stool samples and 147 available stool samples from the 155 vomiting only
episodes (collected within 0–15 days of a vomiting episode) from a birth cohort of 373 children,
followed up to 3 years were screened for the presence of GI and GII norovirus. The enrollment
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criteria and methods for follow up of the cohort, which was established to study rotavirus infec-
tions, included biweekly home visits, fortnightly surveillance stool sampling, monthly anthro-
pometry (weight and length/height) measurements, in addition to collection of samples and
clinical information for all diarrheal episodes [14, 15]. At least one fecal sample was collected
in 98% of diarrheal episodes within one week of onset. Venous blood or saliva was collected
from the children at the end of the study for genetic analysis. Household hygiene was assessed
on a 24-point scale, using a structured questionnaire covering aspects of water, food and per-
sonal hygiene; this questionnaire has previously been validated and used in the same commu-
nity[16]. Written informed consent was obtained from parents of all children prior to the
enrollment, and the study was approved by the Institutional Review Board of the Christian
Medical College, Vellore.
Definition, assessment of severity and etiology of diarrhea
Diarrhea was defined as the passage of3 loose watery stools during a 24‐hr period or in
breastfed children alone, a change in the number or consistency of stools as reported by the
mother. An episode was defined as at least one day of diarrhea, preceded and followed by2
days without diarrhea. The severity of diarrhea was assessed using the Vesikari scoring system
[17] that was developed for rotavirus but has been used to score severity of norovirus diarrhea
in recent studies [8, 11, 18]. An episode was considered mild for a score5, moderately severe
for a score of 6–10 and severe for scores>10. Diarrheal stool samples were screened for para-
site ova and cysts by microscopy, for bacterial pathogens by culture, and for rotavirus by
enzyme-linked immunosorbent assay (Rota IDEIA; Dako, Ely, United Kingdom).
RNA extraction and cDNA synthesis
Viral RNA was extracted from 20% fecal suspension in Minimal Essential Medium using gua-
nidium isothiocyanate and silica [19].The RNA was eluted into 50μl of diethylpyrocarbonate
treated water containing 40 units of RNase inhibitor (Invitrogen, Life Technologies, Paisley,
UK). Complementary DNA (cDNA) was generated by reverse transcription in the presence of
random primers (hexamers) [Pharmacia Biotech, United Kingdom] using Moloney murine
leukemia virus reverse transcriptase (Invitrogen, Life Technologies, Paisley, UK).
PCR for Norovirus GI
Screening of all stool samples from diarrheal episodes and vomiting only episodes for NoV GI
was carried out using primers and conditions previously published [20]. The primers amplify
an 84 bp fragment of the ORF 1–2 regions. Samples that were positive were cloned into the
TOPO TA cloning kit as per the manufacturer’s instructions (Invitrogen, Life Technologies,
UK). Clones were purified using QIAprep Spin Miniprep Kit (Qiagen, Valencia, USA) and sub-
jected to automated sequence analysis.
PCR for Norovirus GII
Two separate PCR reactions were carried out for all the samples using previously published
primers specific to the RNA dependent RNA polymerase (RdRp) and ORF 1–2 regions as per
previously published cycling conditions, amplifying a 113bp and 468bp fragment, respectively
[20, 21]. Samples with amplification using either primer set were considered positive for noro-
virus and sequencing was attempted for all amplicons.
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Sequence Analysis
Sequencing of the positive amplicons was carried out by using the ABI PRISM Big Dye Termi-
nator cycle sequencing ready reaction kit (Applied Biosystems, CA, USA). The amplicons cor-
responding to the ORF 1–2 junction region were sequenced when available; else the RdRp
region was sequenced. Sequences were resolved using an automated DNA sequencer ABI
PRISM 310 Genetic Analyzer. The sequences were imported into BioEdit software (version 7).
Phylogenetic analysis was carried out using reference sequences from the norovirus molecular
epidemiology database (Noronet) at www.rivm.nl and sequences from GenBank. Variants of
NoV GII.4 were detected using the norovirus genotyping tool from http://www.rivm.nl/mpf/
norovirus/typingtool. Neighbor joining method (10000 pseudo replicates) with MEGA soft-
ware (version 4) was used to assign the samples to a genotype based on>90% homology at the
nucleotide level with other strains within a given genotype [22].
Fucosyltransferase 2 (FUT2) genotyping for Secretor Status
Genomic DNA was isolated from buccal epithelial cells or blood using the QIAamp DNAMini
Kit (Qiagen, Hilden, Germany) according to manufacturer’s instructions. The amplification of
a region of the FUT2 gene and genotyping for two single nucleotide polymorphisms (SNPs)
was carried out using published methods [23, 24]. The TaqMan Genotyping Master Mix
(Applied Biosystems) and Custom TaqMan SNP Genotyping Assay for the 428 and 385 SNP
of the FUT2 gene designed by J. Le Pendu, France and M. Lay, USA (Applied Biosystems)
respectively were used in a final volume of 20 μl.
ABO and secretor phenotyping from saliva
Saliva samples that were boiled and cooled were used to coat 96-well high-binding plates
(Costar, Corning, N.Y.) at room temperature for 4hrs and then blocked with 10% non-fat milk
(blotto) overnight at 4°C. After washing, primary antibodies Anti-Lea Gamma-clone (1:100),
Anti-A Gamma-clone (1:200) and Anti-B Gamma-clone (1:100) from ImmucorGamma, Geor-
gia, USA, BG-6 (anti-Leb) antibody (1:100) from Covance, Texas, USA were added and plates
incubated at 37°C for 1hr. This was followed by the addition of a Goat anti-Mouse IgG-HRP
(Sigma, USA) and UEA-1 lectin-HRP (Sigma, USA) at 37°C for 1 hr. The detection was carried
out with TMB peroxidase substrate (KPL, Gaithersburg, MD) and the plates were read at
OD450[25]. A pooled saliva sample and PBS were used as positive and negative controls,
respectively.
Statistical Analysis
The data were analyzed using STATA 10.0 for Windows (STATA Corp., TX, USA). Descriptive
analysis was performed for all explanatory variables. Statistical significance of the observed dif-
ferences in outcome between explanatory variables was assessed using Chi-square test or Fish-
er’s exact test for categorical variables and two-tailed t-test or Mann-Whitney U test for
continuous variables, depending on the distribution of the data. A p-value of<0.05 was consid-
ered statistically significant. Seasonality of norovirus-associated diarrhea was assessed by fitting
a sine curve to a time-series of the monthly stool positivity rates (proportion of diarrheal epi-
sodes attributed to norovirus divided by the total number of diarrheal episodes). The intensity
of the seasonal fluctuation was computed by calculating the peak-to-low ratio using a modified
version of the Edward’s technique [26].Association between distribution of Histo-Blood Group
Antigen and secretor status among the norovirus infected and non-infected individuals were
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ascertained through logistic regression analysis and odds ratios (ORs) with 95% confidence
intervals (CI) calculated.
Height-for age (HAZ), weight-for-height (WHZ) and weight-for-age (WAZ) z-scores were
calculated using the 2006 WHO child growth standards as the reference population [27], and
children classified as stunted (HAZ<-2 SD), wasted (WHZ<-2 SD), underweight (WAZ<-2
SD) or normal based on their respective z-scores.
Results
A total of 1,856 episodes of diarrhea were experienced by the 373 children in the cohort, with a
previously published incidence of gastrointestinal illness of 3.6 per child year in infancy and 1.64
and 1.16 per child year, respectively during the subsequent years [14]. The median (IQR) age of
the first diarrheal episode was 3 (1–6) months. A total of 149 (149/373, 40%) children had 207
episodes of diarrhea associated with norovirus detection (details available in S1 Dataset). Norovi-
rus GI and GII were detected in 49episodes (49/1856, 2.6%) and 150 episodes (150/1856, 8.1%)
of diarrhea respectively; eight (8/1856, 0.4%) episodes were mixed infections with both norovirus
GI and GII. Of the available 147 stool samples from the 155 vomiting only episodes which were
collected within 0–15 days of vomiting, norovirus GI and GII were associated with 7 episodes (7/
147, 4.8%) and 23 episodes (23/147, 15.6%) respectively, and there were no mixed infections.
Table 1 compares the clinical characteristics of diarrheal episodes associated with norovirus
between GI and GII. The median (IQR) age at first symptomatic norovirus infection was 5 (3–
7) months and 8 (5–15) months among norovirus GI and GII respectively. The median (IQR)
duration of a diarrheal episode and proportion associated with vomiting and fever were similar
for the two viral genogroups (Table 1).
Re-infection
One hundred and thirty of the 149 (87.2%) children who ever had a norovirus associated diar-
rhea had only one episode during the 3-year follow-up period. Forty-four of 149 (29.5%) chil-
dren had a re-infection with either genogroup. Children showed a higher rate of re-infection
with norovirus GII (30/123, 24.3%) compared to norovirus GI (6/51, 11.8%). Eight of the 174
children (4.6%) had both norovirus GI and GII infections. Among the 30 children with 2 or
more norovirus GII positive diarrheal episodes, three children experienced the second episode
6, 8 and 9 days after the first episode, which may represent continued shedding.
Only one child (1.9%) with norovirus GI re-infection was re-infected with the same geno-
type and the rest had a different genotype during re-infection (Fig 1). The duration between
primary and re-infection with the same genotype was 270 days. The shortest and longest dura-
tion between re-infection with a different genotype was 26 and 811 days.
Of the 30 children with norovirus GII re-infection, genotype could not be identified for 7
samples. Of the remaining, 12 children were re-infected with the same genotype, three of
whom may have had continuous shedding as stated above, and 11 with a different genotype
(Fig 1). Reinfections with GII.4 in six of nine re-infected children were with different variants
(Table 2). The shortest and longest duration between re-infection with the same genotype,
other than the three who were less than 10 days, were 74 and 534 days. Re-infection with differ-
ent genotypes ranged from 16 days to 767 days.
Presence of co-pathogens
Mixed infections with other pathogens were seen in 56/207 (27%) norovirus-associated diar-
rheal episodes, of which 52 episodes had a single co-pathogen and 4 had two co-pathogens.
The commonest co-pathogen isolated was rotavirus, which was present in 36/56(64.2%)
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episodes of mixed infections, followed by Giardia in 9/56 (16.1%) episodes; other co-pathogens
were: Cryptosporidium (5/56, 8.9%), Aeromonas (4/56, 7.1%), Vibrio (3/56, 5.4%), Shigella (2/
56, 3.6%) and Ascaris (1/56, 1.7%). The comparison of clinical features between diarrheal epi-
sodes of single and mixed infections is presented in Table 3. Episodes of mixed infection had
higher association with comorbidities such as vomiting and fever, and were more severe.
Seasonality of norovirus-associated diarrhea
Norovirus-associated diarrhea was seen to occur during all months of the year, ranging from a
stool positivity rate of 6.2% in November to 17.2% inMay (Fig 2). The peak-to-low (95% CI) ratio
of seasonal intensity of occurrence of norovirus diarrhea was 1.57 (1.05–2.20), suggestive of a mild
increase in the proportion of norovirus-associated diarrheal episodes during the summer season.
Age and norovirus-associated diarrhea
A total of 50 (87.7%) and 98 (62%) episodes of diarrhea in children1 year of age were associ-
ated with norovirus GI and GII respectively. The median age of norovirus diarrhea was 7 (4.5–
Table 1. Comparison of clinical characteristics between norovirus GI and GII diarrheal episodes.
Variable NoV GI NoV GII p-value
Overall Number of episodesa 49 150 —
Median (IQR) duration (in days) 3 (2–4) 3 (2–5) 0.542b
Median (IQR) Vesikari score 5 (5–8) 5 (5–7) 0.749b
Number (%) of episodes with associated vomiting 12 (24.5) 33 (22.8) 0.804c
Number (%) of episodes with associated fever 14 (28.6) 33 (22.8) 0.443c
Before introduction of supplementary feeding Number of episodesa 8 11 —
Median (IQR) duration(in days) 4 (3–5.5) 3 (2–5) 0.399b
Median (IQR) Vesikari score 5 (4.5–6) 5 (5–7) 0.465b
Number (%) of episodes with associated vomiting 0 (0%) 3 (27.3) 0.228d
Number (%) of episodes with associated fever 1 (12.5) 2 (18.2) 1.000d
After introduction of supplementary feeding Number of episodesa 41 134 —
Median (IQR) duration(in days) 3 (2–4) 3 (2–5) 0.848b
Median (IQR) Vesikari score 6 (5–8) 5 (5–7) 0.475b
Number (%) of episodes with associated vomiting 12 (29.3) 30 (22.4) 0.367c
Number (%) of episodes with associated fever 13 (31.7) 31 (23.1) 0.268c
During infancy Number of episodesa 42 86 —
Median (IQR) duration(in days) 3 (2–4) 3 (2–5) 0.630b
Median (IQR) Vesikari score 5 (5–8) 6 (5–9) 0.291b
Number (%) of episodes with associated vomiting 9 (21.4) 23 (26.7) 0.514c
Number (%) of episodes with associated fever 11 (26.2) 22 (25.6) 0.941c
Post infancy (2nd and 3rd year of life) Number of episodes 7 59 —
Median (IQR) duration (in days) 3 (2–5) 2 (2–3) 0.229b
Median (IQR) Vesikari score 7 (6–8) 5 (4–7) 0.023b
Number (%) of episodes with associated vomiting 3 (42.9) 10 (16.9) 0.131d
Number (%) of episodes with associated fever 3 (42.9) 11 (18.6) 0.159d
a = Includes both primary and secondary infections
b = Mann-Whitney U test
c = Chi-square (χ2) test
d = Fisher’s exact test
doi:10.1371/journal.pone.0157007.t001
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12) months. Median age (IQR) of diarrhea with norovirus GI and GII were 5 (3–7) months
and 8.8(5.7–15.3) months respectively. The median (IQR) duration in infants was similar
between the two genogroups of the virus (Table 1). Diarrheal severity was greater in norovirus
Fig 1. Norovirus genotypes in primary and subsequent diarrheal episodes in children who hadmore
than one infection. Each line represents one child with re-infection, while the age in months is on the x- axis.
Norovirus genotypes are represented by symbols. Samples that failed sequencing have been denoted as
Failed in the figure. A) Children with re-infections with either norovirus GI and GII. B) All norovirus GI infection
children who were re-infected with either GI or GII noroviruses. GI genotypes are shown, while GII infections
are shown only as genogroup. C) All norovirus GII infection children who were re-infected with either GI or GII
noroviruses. GII genotypes are shown while GI infections are shown only as genogroup.
doi:10.1371/journal.pone.0157007.g001
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GII episodes occurring during infancy (Median [IQR] Vesikari score = 6 [5–9]) than at a later
age (Median [IQR] Vesikari score = 5 [4–7], p = 0.016); this was reversed for norovirus GI epi-
sodes, although the difference was not statistically significant (Median [IQR] Vesikari score = 5
[5–7] vs. 7 [6–8], p = 0.111). No difference in associated vomiting or fever between episodes
occurring below and above the age of 1 year was observed among the two viral genogroups.
The overall incidence of norovirus diarrhea was 0.14 (0.12–0.16) per child-year which is
lower than the incidence of rotavirus diarrhea in the same population, 0.25 (0.22–0.29) per
Table 2. Distribution of norovirus variants of GII.4.
Child No.* Sample No. ORF2 ORF2_variant ORF2_variant
8 CRI6134 GII.4 Hunter_2004 II.4|2004
CRI8497 GII.4 Hunter_2004 II.4|2004
9 CRI3819 GII.4 Lanzou_2002 II.4|2002CN
CRI4419 GII.4 Lanzou_2002 II.4|2002CN
11 CRI7807 GII.4 US95_96 II.4|1995
CRI16705 GII.4 Hunter_2004 II.4|2004
17 CRI5799 GII.4 Lanzou_2002 II.4|2002CN
CRI11124 GII.4 Hunter_2004 II.4|2004
19 CRI14276 GII.4 Kaiso_2003 II.4|2003
CRI30481 GII.4 Asia_2003 II.4|2005
22 CRI19650 GII.4 Hunter_2004 II.4|2004
CRI28799 GII.4 Asia_2003 II.4|2005
32 CRI2563 GII.4 Lanzou_2002 II.4|2002CN
CRI19884 GII.4 Hunter_2004 II.4|2004
37 CRI24530 GII.4 Hunter_2004 II.4|2004
CRI31001 GII.4 Hunter_2004 II.4|2004
40 CRI9506 GII.4 Kaiso_2003 II.4|2003
CRI17383 GII.4 Hunter_2004 II.4|2004
*Child number denotes the child in the Fig 1C.
doi:10.1371/journal.pone.0157007.t002
Table 3. Comparison of clinical features between diarrheal episodes of single infections with norovirus andmixed infections of norovirus and
other enteric pathogens.
Norovirus GI Norovirus GII
Clinical features Single infection
(N = 47)
Mixed infection
(N = 9)a
p-
value
Single infection
(N = 105)
Mixed infection
(N = 47)b
p-
value
Number (%) of episodes with associated
vomiting
9 (19.2) 4 (44.4) 0.189c 18 (17.1) 16 (34.0) 0.021e
Number (%) of episodes with associated
fever
15 (36.2) 1 (11.1) 0.421c 18 (17.1) 17 (36.2) 0.010e
Number (%) of episodes with associated
dehydration
5 (10.6) 1 (11.1) 1.000c 7 (6.7) 6 (13.0) 0.205e
Median (IQR) Vesikari score 5 (5–8) 7 (5–8) 0.356d 5 (5–7) 6 (5–9) 0.045d
a = Co-pathogens isolated: Rotavirus, Giardia, Aeromonas
b = Co-pathogens isolated: Rotavirus, Giardia, Cryptosporidium, Vibrio, Shigella,Aeromonas, Ascaris
c = Fisher’s exact test
d = Mann-Whitney U test
e = Chi-square (χ2) test
doi:10.1371/journal.pone.0157007.t003
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child-year (Gladstone et al., personal communication). The incidence of norovirus diarrhea
was highest during the first year of life, 0.26 (0.22–0.32) per child-year and decreased to 0.09
(0.07–0.13) and 0.07 (0.05–0.10) per child-year during the second and third year, respectively.
Breastfeeding and norovirus-associated diarrhea
Eight (8/57, 14%) GI and 11 (11/158,7%) GII associated diarrheal episodes occurred before the
introduction of supplementary feeding or weaning (Table 1). No significant patterns were
observed in the duration (IQR) of breastfeeding among the norovirus infected (n = 149, 3 [1–
4] months) and uninfected children (n = 224, 2 [1–3] months); p = 0.753. There was no differ-
ence in the severity of diarrheal episodes, vomiting or febrile symptoms pre- and post-weaning
in children with either genogroup.
Household hygiene and norovirus-associated diarrhea
The median (IQR) household hygiene score among the norovirus infected and uninfected chil-
dren was 11 (8–14) and 11 (9–13.5), respectively (p = 0.500). When the household hygiene
scores were compared between children with single (n = 105, 11 [8–13]) and multiple (n = 44,
10 [7–14]) norovirus infections, they were found to be similar (p = 0.730). Similarly, children
with only GI infections (n = 26, 10[8–13]) had comparable hygiene scores to children with
only GII (n = 98, 11 [8–14],p = 0.758) infections.
Growth and norovirus-associated diarrhea
Complete anthropometry data was available for 362 (97.1%) of the 373 children under observa-
tion. The proportion (with 95% CI) of stunted, wasted and underweight children at 12, 24, and
36months of age among those with and without norovirus infection is presented in Fig 3. The
proportions of stunted, wasted and underweight children were comparable between those with
and without norovirus infection at all the three time points. However, when the anthropomet-
ric data were compared between children with single and multiple norovirus infections, a
higher proportion of children with multiple infections were stunted (61.9 vs. 41.7%, p = 0.027)
and wasted (16.7% vs. 3.9%, p = 0.014) at 12 and 24 months of age, respectively (Fig 3). The
proportion of stunted, wasted and underweight children was comparable between children
with norovirus GI and GII infections.
Fig 2. Seasonal fluctuations in the monthly occurrence of episodes of norovirus-associated diarrhea.
The y-axis represents the monthly stool positivity rates (proportion of diarrheal episodes attributed to
norovirus divided by the total number of diarrheal episodes). The x-axis represents the month of the year.
doi:10.1371/journal.pone.0157007.g002
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Fig 3. Proportion (with 95% CI) of (A) stunted, (B) wasted and (C) underweight children at 12, 24 and
36months of age. The y-axis depicts the proportion of children with growth deficiency whereas the x-axis
represents age in months. The point prevalence is presented as a circle and the 95% CI is represented as
Norovirus Gastroenteritis in Indian Children
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Genotyping
A total of 215 samples were genotyped by sequencing of the amplicons. Three GI and 26 GII
samples failed in sequencing reactions, but are included in the overall analysis because all PCRs
were repeated at least twice, and band sizes re-confirmed with absence of non-specific bands.
Sequence analysis of the GI genogroups showed a predominance of GI.3 genotype in 23/57
(40.3%) of the samples, followed by GI.1 (15/57, 26.3%), GI.2 (9/57, 15.7%) and GI.6 (6/57,
10.5%). Phylogenetic analysis of norovirus GII genogroup of either the capsid or the RdRp
region (Fig 4) showed the predominance of GII.4 genotype in 70/132 (53.0%) of the samples,
followed by GII.2 (28/132, 21.2%) and GII.3 (18/132,13.6%), respectively.
The GII.4 strains were placed in 3 sub-clusters when analyzed with reference sequences. Of
the 35 samples identified as GII.4 at the ORF 1–2 capsid junctions, 17 strains with 96% nucleo-
tide identity clustered in the Hunter sub-cluster, 6 with 93% nucleotide identity with the Far-
mington sub-cluster and 12 with 98% nucleotide identity with the Sakai sub-cluster. Fifteen
children between the ages of 2.5–8.3 months were infected with the Hunter sub-cluster, with 2
children having two episodes of infection 17 and 159 days apart, respectively. Six children
between the ages of 4.2–8.6 months were infected with the Farmington sub-cluster. The Hunter
and Farmington sub-cluster infections were seen in children between the years 2002–2003, indi-
cating the circulation of this sub-cluster in the community. However, there was a predominance
of the Sakai sub-cluster in 12 children who were infected between 2004–2005. Nine samples were
genotyped as GII.3 and clustered with 94% nucleotide identity to the Toronto strain. Ten samples
were genotyped as GII.2 with 98% nucleotide identity to the SnowMountain strain.
Nucleotide sequences of positive samples from the study have been deposited in the Gen-
Bank and the accession numbers are JN654720-JN654766.
Association of blood group and secretor status with norovirus infection
ABO blood group and secretor status were determined for 293 children from whom appropri-
ate samples were available. The most common ABO blood group was O (39.3%), followed by B
(32.5%), A (20.9%) and AB (7.2%). One hundred eighty-six children (186/305, 60.9%) were
secretor positive.
Secretor status was significantly associated with overall norovirus GI (Table 4), but not with
norovirus GII infection (Table 5). No significant association between the ABO blood group and
norovirus GI or GII infection was observed (Tables 4 and 5). Among the 48 children with GI
infection, those with GI.1 genotype (n = 15) were all secretor positive, whereas among the children
with non GI.1 infection (n = 33), 84.9% were secretor positives although the difference was not
statistically significant (p = 0.167). For the 115 children with GII infection, 75% of those with
GII.4 (n = 56) were secretor positives, whereas only 57.8% of children with non GII.4 infection
(n = 57) were secretor positives (p = 0.054). Moreover, genotyping for the FUT2 SNP showed that
children with the G428A homozygous mutation for inactivation of the FUT2 enzyme (se428se428)
are significantly at a lower risk of infection with norovirus (Tables 4 and 5). There was no signifi-
cant association between norovirus diarrhea with any genotype with any specific blood group.
Discussion
This is the first longitudinal study of norovirus gastroenteritis in a birth cohort of children in
India. Most estimates of disease burden are based on hospital studies, which sample the more
vertical lines. The solid vertical line represents uninfected children, the dashed and dotted lines represent
those with single and multiple norovirus infections, respectively.
doi:10.1371/journal.pone.0157007.g003
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severe end of the spectrum of disease, and do not have community based denominator data. In
this birth cohort from an urban slum in southern India, norovirus was a significant cause of
diarrhea, associated with 11.2% of episodes, second only to rotavirus, and affecting almost half
the cohort. In a recent study from India, 10.7% positivity was found in children<7 years of
age, with 40% positivity in the1 year olds [10], but this was a cross-sectional study in chil-
dren presenting to hospital with gastroenteritis. Community based studies from developed
countries like Europe have reported higher norovirus rates, 24.5% in children<5, and 28% in
those1 year old in the UK [28], and in the Netherlands, 14% in children<4 years and 14.3%
in children1 year of age [29], but these findings are in settings where higher rates of viral gas-
troenteritis are reported in children presenting to hospitals than in developing countries.
A majority of the norovirus reports from developing countries are hospital based and the
detection ranges from 5.5% in Vietnam, 15% in Nicaragua, 9.3% in Tunisia, 30% in Iraq, 3.7%
in Brazil and 32.1% in urban Peru, 11.3% in Malawi and 14% in Guatemala [30–37]. Two
cohort studies carried from Chile and Peruvian Amazon have shown 18% and 25% of acute
Fig 4. Dendrogram constructed using neighbor joining of nucleotide sequences corresponding to
fragment of 468 bp of the ORF 1–2 region of the Norovirus capsid encoding gene. Bootstrap values for
10000 pseudo replicates are shown. The reference strains included for comparison with accession numbers
are: Hunter284/04/AU (DQ078794), Farmington Hills/02/US (AY502023), Sakai/04-179/05/JP (AB220922),
Bristol/1993/UK (X76716), Maizuru/010426/2001/JP (EF547404), M7/1999/US (AY130761), Toronto/1991/
CA (AAA18930), Seacroft/1990/UK (AJ277620), Hu/SaitamaU16/197/JP (AB039778), Erfurt546/2000/DE
(AF427118), Mc37/2001/TH (AY237415), Wortley/1990/UK (AJ277618), Chitta/1996/JP (AB032758), Snow
Mountain/1976/US (AY134748), Melksham/95/UK (X81879), KY-89/1989/JP (L23828), Norwalk/1968/US
(M87661).
doi:10.1371/journal.pone.0157007.g004
Norovirus Gastroenteritis in Indian Children
PLOS ONE | DOI:10.1371/journal.pone.0157007 June 10, 2016 12 / 18
diarrhea episodes in children<24 months were due to norovirus respectively [38, 39]. A
recently published birth cohort study among children from Peruvian urban community
showed a prevalence of 22.8% among the diarrheal stool samples screened[13]. In our study, a
significantly higher proportion of children with multiple infections were stunted, wasted and
underweight at age 12 and 24 months irrespective of genotype which is in contrast to that seen
among children from the Peruvian study where GII exhibited a more significant effect[13].
Table 4. Distribution of Histo-Blood Group and Secretor status among norovirus GI infected and non-infected individuals.
Norovirus GI infected (n = 48) Norovirus GI negative (n = 257) OR 95% CI p- value
Blood Group
O 22 (46%) 98 (38%) 1.57 (0.66–3.76) 0.31
B 15 (31%) 84 (33%) 1.25 (0.50–3.14) 0.64
AB 3 (6%) 19 (7%) 1.11 (0.27–4.60) 0.89
A 8 (17%) 56 (22%) 1
Secretor Phenotype
Secretor 43 (90%) 157 (61%) 5.48 (2.09–14.29) 0.001
Non-Secretor 5 (10%) 100 (39%) 1
Genotyping for FUT2 SNP (428G>A)
Se428Se428 23 (48%) 130 (51%) 1
Se428se428 13 (27%) 67 (26%) 1.22 (0.62–2.39) 0.56
se428se428 12 (25%) 60 (23%) 0.32 (0.11–0.96) 0.04
Genotyping for FUT2 SNP (385A>T)
Se385Se385 21 (44%) 72 (28%) 1
Se385se385 20 (42%) 96 (37%) 0.71 (0.36–1.42) 0.34
se385se385 7 (14%) 89 (35%) 0.27 (0.11–0.67) 0.01
SeSe: Homozygous wildtype for FUT2; Sese: Heterozygous for inactivation of FUT2;sese: Homozygous for inactivation of FUT2
doi:10.1371/journal.pone.0157007.t004
Table 5. Distribution of Histo-Blood Group and Secretor status among norovirus GII infected and non-infected individuals.
Norovirus GII infected (n = 115) Norovirus GII negative (n = 190) OR 95% CI p-value
Blood Group
O 43 (37%) 77 (41%) 0.93 (0.50–1.75) 0.82
B 38 (33%) 61 (32%) 1.04 (0.54–1.99) 0.91
AB 10 (9%) 12 (6%) 1.39 (0.52–3.70) 0.51
A 24 (21%) 40 (21%) 1
Secretor Phenotype
Secretor 77 (67%) 123 (65%) 1.10 (0.68–1.80) 0.69
Non-Secretor 38 (33%) 67 (35%) 1
Genotyping for FUT2 SNP (428G>A)
Se428Se428 68 (59%) 89 (47%) 1
Se428se428 31 (27%) 53 (28%) 0.77 (0.44–1.32) 0.34
se428se428 16 (14%) 48 (26%) 0.44 (0.23–0.83) 0.01
Genotyping for FUT2 SNP (385A>T)
Se385Se385 33 (29%) 60 (32%) 1
Se385se385 44 (38%) 72 (38%) 1.11 (0.63–1.96) 0.72
se385se385 38 (33%) 58 (31%) 1.19 (0.66–2.15) 0.56
SeSe: Homozygous wildtype for FUT2; Sese: Heterozygous for inactivation of FUT2; sese: Homozygous for inactivation of FUT2
doi:10.1371/journal.pone.0157007.t005
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Children who had vomiting only episodes had high positivity for norovirus GI or GII (30/
147, 20.4%) in stool compared to the proportion of diarrheal stools positive for norovirus (215/
1856, 11.6%). Earlier studies on children have reported a higher percentage of vomiting epi-
sodes than diarrheal episodes in norovirus associated outbreaks of gastroenteritis, described as
'winter vomiting disease'[40].A study on norovirus gastroenteritis in military trainees from the
USA also reported a higher norovirus positivity in vomiting episodes (80%) compared to diar-
rheal episodes (67%)[41].
The median Vesikari score for norovirus GI and GII diarrhea was 5, similar to studies from
other developing countries [8, 42], and was less severe than that associated with rotavirus dis-
ease in this cohort, which had a median severity score of 7.6 [43]. The median age of the first
symptomatic infection of norovirus GI and GII was 5 and 8 months respectively, slightly youn-
ger than 9 months and 11 months as reported from studies in Chile and Brazil, respectively [8,
44].In a study examining the global age distribution of pediatric norovirus cases, approximately
70% of norovirus cases occurred in the age group between 6 months to 2 years [45]. The study
recommended completion of norovirus vaccination in children by 6 months of age to poten-
tially prevent a greater burden of disease compared to completion of vaccination at 12 months.
The recommendation would hold true for our study population where the median age (IQR) of
norovirus diarrhea was 7 (4.5–12) months. Early completion of immunization is likely to have
a greater benefit in reducing disease burden, particularly for GII infections where the primary
infection was more severe.
The severity and frequency of vomiting and fever associated with norovirus was higher
among the GII infected children (Table 1); this finding is similar to studies from Peru [13, 38].
In human volunteer challenge studies and vaccine trials, the definition of norovirus illness
includes individuals who experience only vomiting in the absence of diarrhea as a clinical end-
point [46–48]. In this study, the examination of stool samples from children who presented
with vomiting alone as a primary clinical symptom suggests that there may be an underestima-
tion of norovirus disease burden by exclusion of cases presenting with vomiting only.
Symptomatic norovirus associated diarrhea was detected in children during the first 6
months of age suggesting that breast feeding did not confer protection, unlike the absence of
symptomatic infection among younger children in the Peruvian study [13]. Re-infection with
norovirus was associated with diarrhea in a quarter of ever-infected children, this is in contrast
with reports from the Chilean birth cohort where 40% (10/25) of re-infections with norovirus
were symptomatic, the lower number of re-infections seen could be due to the difference in
size of the study population [8]. In the birth cohort from Peru, repeat infections by the same
genogroup of norovirus were seen, but the majority of the reinfections were by a different geno-
type or variant of GII.4. The GII.4 variants described in Peru were 2006b, 2007, 2008 and 2010
[13]. The data in this study showed higher rates of reinfections with the same genogroup and
genotype of norovirus than in Peru. Since these studies were carried out in distinct time periods
(Vellore, 2002–2006 and Peru, 2007–2011), some of these differences may be due to the differ-
ence in circulating GII.4 variants between the two studies (Table 2).Re-infection with the same
genogroup and genotype was observed in this study suggesting that lower genogroup or geno-
type specific immunity may occur in India, in contrast to the Peruvian study where genotype-
specific immunity was observed[13].
A high degree of genetic diversity was seen among circulating noroviruses, with four GI
genotypes and nine genotypes of norovirus GII detected. These data are similar to other studies
where a higher diversity of norovirus has been documented in gastroenteritis in the community
when compared to outbreaks, generally in the adult and/or elderly population [4, 28, 49–53].
GI.3 (40.3%) was the predominant strain detected in the cohort followed by GI.1 (26.3%), GI.2
(15.7%) and GI.6 (10.5%). GII.4 was the predominant genotype while GII.2 (17.7%) and GII.3
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(11.4%) were also detected in significant proportions, similar to previous reports [28, 49].
Other studies in India have reported a predominance of GII.4 strains; however, these were pre-
dominantly outbreaks studies [9, 10]. The GII.4 strains detected in the current study clustered
into3sub-clusters, with a temporal distribution of the Hunter sub-cluster being replaced by Far-
mington and then by Sakai. Evolutionary analysis studies have shown that the newer strains
originate by amino acid changes due to positive selection and recombination which drives the
persistence of newer strains in the human population [54].
The link between the Histo-Blood Group Antigen (HBGA) binding and secretor status is
well documented for the prototype GI virus, Norwalk virus. In this study, there was no signifi-
cant association between blood groups and norovirus GI infection, but higher infection rates
were seen among secretors compared to non-secretors, which is similar to previous studies of
volunteer challenge and in vitro binding studies that have shown that carbohydrate binding is
essential for GI infection [23, 55–57]. There was no significant association between blood
groups or secretor status with norovirus GII infection which is consistent with other reports
that have shown no association between host genetic factors and symptomatic infection of nor-
ovirus GII[58–60]. Expression of the FUT2 gene and susceptibility to norovirus infection was
examined by checking for two common mutations in Asian populations, which showed that
children with a nonsense mutation at G428A were significantly at a lower risk of infection with
norovirus, as has been previously shown by other studies [61, 62].
In summary, this report shows that norovirus infections are a common cause of pediatric
gastroenteritis in southern India. A previous report from the same region found 15% of hospi-
talized gastroenteritis cases in children<5 years of age to be positive for norovirus [9]. In the
community, norovirus infections were associated with mild disease, but symptomatic re-infec-
tions were common. The continued replacement of strains in the population suggests the need
for strain specific vaccines, or identification of epitopes that are conserved across the norovirus
variants could be used to generate broadly protective vaccines. In order to assess the true rate
of infection with noroviruses in this community and the role of prior infections in protection
from subsequent infection or disease, the investigation of asymptomatic shedding and immune
responses would be of interest.
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